Fetzima (levomilnacipran) is a selective serotonin and norepinephrine reuptake inhibitor antidepressant (SNRI). Levomilnacipran affects chemicals in the brain that may be unbalanced in people with depression.
Fetzima is used to treat major depressive disorder.
A similar medicine called milnacipran (Savella) is used to treat a chronic pain disorder called fibromyalgia. Fetzima should not be used to treat fibromyalgia.
Note: This page contains information about the side effects of levomilnacipran. Some of the dosage forms included on this document may not apply to the brand name Fetzima.
Common side effects of Fetzima include erectile dysfunction, nausea, and orthostatic hypotension. Other side effects include urinary hesitancy, ejaculatory disorder, testicular pain, premature ejaculation, increased heart rate, palpitations, tachycardia, constipation, vomiting, epididymitis, sinus tachycardia, delayed ejaculation, ejaculation failure, and hyperhidrosis. See below for a comprehensive list of adverse effects.
Fetzima dosage information: Fetzima (levomilnacipran hydrochloride) capsule, extended release General dosage information for the active ingredient contained in Fetzima: Levomilnacipran (oral capsule, extended release) Please confirm that the medication forms on the dosage document(s) above are relevant for the specific drug you are interested in.